Library

CBDVA

CBDVA is the carboxylic-acid precursor of cannabidivarin (CBDV); heating or vaping will largely decarboxylate it into CBDV. Pre-clinical data suggest anticonvulsant, anti-inflammatory, and 5-HT1A-mediated anti-nausea properties similar to CBDA, but human data are sparse. Like CBD, CBDVA appears to inhibit CYP3A4, CYP2C19 and CYP2C9, so therapeutic drug monitoring is advised when combined with narrow-therapeutic-index medications (e.g., warfarin, clobazam, tacrolimus). Because it is non-intoxicating, subjective effects are subtle; many users report clearer focus and reduced anxiety rather than overt euphoria. Long-term safety data are lacking; start low, especially if you have liver disease or take hepatically-metabolized drugs.

CBDVA molecular structure
CBDVA molecular structure diagram from the DrugsPRO substance library.

Also known as: Cannabidivarinic acid

Classification

  • Chemical: Cannabinoid
  • Chemical: Medicine
  • Tag: Not psychoactive
  • Tag: Research-Chemical
  • Tag: Supplement

Effects

  • Anxiolysis
  • Reduced Inflammation Perception
  • Anticonvulsant Effects
  • Mild Stimulation At Low Doses
  • Sedation At Higher Doses
  • Antiemetic Effects
  • Subtle Relaxation
  • Mild Mood Elevation
  • Increased Focus

Routes of Administration

Oral

Dosage

  • Threshold: 5 mg
  • Light: 10-40 mg
  • Common: 40-100 mg
  • Strong: 100-200 mg
  • Heavy: 200 mg

Duration

  • Onset: 0.5-1.5 h
  • Comeup: 0.5-1 h
  • Peak: 2-4 h
  • Offset: 2-4 h
  • After Effects: 12 h

Sublingual

Dosage

  • Threshold: 3 mg
  • Light: 5-25 mg
  • Common: 25-80 mg
  • Strong: 80-150 mg
  • Heavy: 150 mg

Duration

  • Onset: 0.25-0.75 h
  • Comeup: 0.33-0.67 h
  • Peak: 1.5-3 h
  • Offset: 1.5-3 h
  • After Effects: 8 h

Vaporized

Dosage

  • Threshold: 2 mg
  • Light: 5-15 mg
  • Common: 15-40 mg
  • Strong: 40-80 mg
  • Heavy: 80 mg

Duration

  • Onset: 0.02-0.08 h
  • Comeup: 0.08-0.25 h
  • Peak: 0.17-0.5 h
  • Offset: 1-2 h
  • After Effects: 6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

CBDVA - DrugsPRO ainejuhend

CBDVA: CBDVA is the carboxylic-acid precursor of cannabidivarin (CBDV); heating or vaping will largely decarboxylate it into CBDV. Pre-clinical data suggest anticonvulsant, anti-inflammatory, and 5-HT1A-mediated anti-nausea properties similar to CBDA, but human data are sparse. Like CBD, CBDVA appea

Related pages